首頁 > 市場調查報告書 > 醫療設備

灌注系統市場規模、佔有率和成長分析（按年齡、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

市場調查報告書

商品編碼

1900212

灌注系統市場規模、佔有率和成長分析（按年齡、應用、最終用戶和地區分類）—產業預測（2026-2033 年）

Perfusion System Market Size, Share, and Growth Analysis, By Age Group (Adults, Pediatrics), By Application (Cardiopulmonary Perfusion System, Cell Perfusion System), By End User, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，全球灌注系統市場規模將達到 13.4 億美元，到 2025 年將達到 13.9 億美元，到 2033 年將達到 18.9 億美元，預測期（2026-2033 年）的複合年成長率為 3.9%。

全球灌注系統市場對醫療保健和生物醫學研究至關重要，尤其是在器官移植和細胞研究領域。這些專用設備能夠將富含氧氣和營養物質的液體可控地輸送到體外的生物組織和器官，因此對於在運輸和實驗室中維持器官活性至關重要。器官移植需求的不斷成長正在推動市場成長，因為灌注系統對於保存和評估捐贈器官至關重要，最終有助於提高移植成功率。灌注技術的進步，例如常溫灌注，延長了器官保存時間，並提高了器官活性評估的準確性。此外，這些系統在藥物和生物技術研究中也發揮關鍵作用，它們能夠促進細胞和組織培養，幫助研究疾病機制並開發新型治療方法。對先進技術和研發舉措的持續投入預計將推動市場持續成長。

全球灌注系統市場促進因素

器官衰竭發病率的上升以及移植器官需求的不斷成長，正顯著推動全球體外循環灌注系統市場的發展。這些先進的系統對於保存和評估捐贈器官至關重要，有助於提高移植手術的整體成功率。隨著醫學界致力於改善移植患者的預後，對體外循環灌注技術的依賴性日益增強。這一趨勢凸顯了有效器官管理策略的重要性，並推動了體外循環灌注設備的創新和投資，以滿足移植領域不斷成長的需求。總而言之，這些因素正在塑造一個充滿活力且不斷擴張的市場格局。

限制全球灌注系統市場的因素

全球體外循環系統市場面臨嚴峻的挑戰，這主要歸因於嚴格的監管要求，這些要求強制規定必須遵守嚴格的安全性和有效性標準。這些合規要求可能會阻礙創新步伐，並延緩新型體外循環技術的市場推廣。由於企業努力遵守這些法規，核准流程往往漫長而複雜，這可能會阻礙企業及時獲得先進的解決方案。進而，這會限制對高性能體外循環系統的需求，影響整體市場成長以及市場快速反應不斷變化的醫療需求和技術進步的能力。

全球灌注系統市場趨勢

全球灌注系統市場正經歷顯著成長，這主要得益於常溫灌注技術的日益普及。這種創新方法能夠在運輸過程中將移植器官維持在生理溫度下，徹底革新了器官保存和評估領域，從而提高了器官存活率和移植成功率。隨著醫療專業人員和移植中心逐漸認知到延長器官保存時間和更精確評估器官功能的潛在益處，對先進灌注技術的需求也不斷成長。此外，持續進行的旨在最佳化灌注液的研發工作也推動了這一趨勢，進一步鞏固了常溫灌注在移植和重症監護領域的重要作用。

心肺灌注系統
- 氧合設備
- 體外循環機
- 灌注幫浦
- 套管
- 監控系統
- 其他
- 動脈濾器
- 儲存
- 資料管理系統
- 心臟麻痹藥物輸送系統
- 熱交換器
- 配件
細胞灌注系統
- 生物反應器灌注系統
- 微流體灌注系統
- 重力/壓力驅動灌注系統
- 小乳腺器官灌注系統
離體器官灌注系統
- 低溫
- 正常體溫
體外膜氧合（ECMO）
離體器官灌注系統

全球灌流系統市場規模（依最終用戶分類），複合年成長率（2026-2033 年）

醫院和門診手術中心（ASC）
專科診所
其他

全球灌流系統市場規模，複合年成長率（2026-2033）

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

ICU Medical（United States）
B. Braun（Germany）
Delcath Systems（United States）
Fresenius Medical Care（Germany）
Terumo Corporation（Japan）
Medtronic（Ireland）
Getinge AB（Sweden）
LivaNova（United Kingdom）
Edwards Lifesciences（United States）
Nipro Corporation（Japan）
CytoSorbents Corporation（United States）
Spectrum Medical（United Kingdom）
Eurosets（Italy）
Biomedica（Austria）
Soma Technology（United States）

結論與建議

簡介目錄

Product Code: SQMIG35G2252

Global Perfusion System Market size was valued at USD 1.34 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 1.89 Billion by 2033, growing at a CAGR of 3.9% during the forecast period (2026-2033).

The global perfusion system market is essential in medical and biomedical research, notably for organ transplantation and cellular studies. These specialized devices enable the controlled flow of oxygenated and nutrient-rich fluids through biological tissues or organs outside the body, crucial for maintaining organ viability during transport and laboratory experiments. The increasing demand for organ transplants drives market growth, as perfusion systems are vital for preserving and assessing donor organs, ultimately enhancing transplant success rates. Advances in perfusion technology, such as normothermic perfusion, allow for longer maintenance and better organ viability assessments. Additionally, these systems play a critical role in pharmaceutical and biotechnology research by facilitating cell and tissue culturing, thereby supporting disease mechanism studies and novel treatment developments. The market is poised for continued growth as investments in advanced technologies and research initiatives expand.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Perfusion System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Perfusion System Market Segments Analysis

Global Perfusion System Market is segmented by Age Group, Application, End User and region. Based on Age Group, the market is segmented into Adults and Pediatrics. Based on Application, the market is segmented into Cardiopulmonary Perfusion System, Cell Perfusion System, Ex-Vivo Organ Perfusion System, Extracorporeal Membrane Oxygenation (ECMO) and Isolated Organ Perfusion Systems. Based on End User, the market is segmented into Hospitals & ASCs, Specialty Clinics and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Perfusion System Market

The rising incidence of organ failure, coupled with a heightened demand for transplantable organs, significantly propels the Global Perfusion System market. These advanced systems are crucial for the preservation and evaluation of donor organs, thereby enhancing the overall success rates of transplantation procedures. As the healthcare sector focuses on improving outcomes for patients in need of transplants, the reliance on perfusion technologies becomes increasingly vital. This trend underscores the importance of effective organ management strategies, driving innovation and investment in perfusion devices to meet the growing needs within the transplant community. Overall, these factors contribute to a dynamic and expanding market landscape.

Restraints in the Global Perfusion System Market

The Global Perfusion System market faces significant challenges due to stringent regulatory requirements that necessitate adherence to rigorous standards for safety and efficacy. These compliance mandates can impede the pace of innovation and delay the introduction of new perfusion technologies into the market. As companies strive to meet these regulations, the often lengthy and complex approval processes can hinder timely access to advanced solutions. Consequently, the demand for enhanced perfusion systems may be stifled, affecting overall market growth and the ability to respond swiftly to evolving healthcare needs and technological advancements in the field.

Market Trends of the Global Perfusion System Market

The global market for perfusion systems is witnessing significant growth driven by the increasing adoption of normothermic perfusion techniques. This innovative approach, which maintains donor organs at physiological temperatures during transport, is revolutionizing organ preservation and assessment, leading to enhanced viability and improved transplant success rates. As healthcare professionals and transplant centers recognize the potential benefits of extended protection times and better evaluations of organ function, demand for advanced perfusion technology is on the rise. This trend is also fueled by ongoing research and development efforts aimed at optimizing perfusion solutions, further solidifying normothermic perfusion's role in transplantation and critical care.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Perfusion System Market Size by Age Group & CAGR (2026-2033)

Market Overview
Adults
Pediatrics

Global Perfusion System Market Size by Application & CAGR (2026-2033)

Market Overview
Cardiopulmonary Perfusion System
- Oxygenators
- Heart-Lung Machine
- Perfusion Pumps
- Cannula
- Monitoring System
- Others
- Arterial Filters
- Reservoirs
- Data Management Systems
- Cardioplegia Delivery Systems
- Heat Exchangers
- Accessories
Cell Perfusion System
- Bioreactor Perfusion System
- Microfluidic Perfusion System
- Gravity/Pressure-driven Perfusion System
- Small Mammal Organ Perfusion System
Ex-Vivo Organ Perfusion System
- Hypothermic
- Normothermic
Extracorporeal Membrane Oxygenation (ECMO)
Isolated Organ Perfusion Systems

Global Perfusion System Market Size by End User & CAGR (2026-2033)

Market Overview
Hospitals & ASCs
Specialty Clinics
Others

Global Perfusion System Market Size & CAGR (2026-2033)

North America (Age Group, Application, End User)
- US
- Canada
Europe (Age Group, Application, End User)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Age Group, Application, End User)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Age Group, Application, End User)
- Brazil
- Rest of Latin America
Middle East & Africa (Age Group, Application, End User)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

ICU Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
B. Braun (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Delcath Systems (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fresenius Medical Care (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Terumo Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Getinge AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LivaNova (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Edwards Lifesciences (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nipro Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CytoSorbents Corporation (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Spectrum Medical (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurosets (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomedica (Austria)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Soma Technology (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments